Phase 1/2, Multi-center, Open-label, Dose Escalation and Dose Expansion First -In-Human Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Efficacy of MHB036C in Participants with Advanced or Metastatic Solid Tumors

Project: Research

Project Details

StatusFinished
Effective start/end date24/02/23 → 24/02/25

Keywords

  • clinical trial
  • Solid Tumors
  • Metastatic cancer
  • Antibody-drug conjugates

Clinical Trial Phase

  • Phase I
  • Phase II